Table 2 Shows the demographic, clinical and metabolic characteristics of T2DM subjects with established IHD compared those without IHD.

Females

Males

Both

Females

Males

Both

P value Both

No

66

83

149

20

52

72

Age

44 (1.3)

41(1.2)

41.7 (1.14)

47 (2.8)

48 (1.4)

47.9 (1.3)

0.001

BMI

29.5(0.7)

32 (1.4)

31 (0.84

31.2 (0.95)

28 (0.60)

28.7 (0.55)

0.35

TG (mmol/L)

1.71(1.08))

2.1(1.08)

1.96(1.06)

1.91(1.16)

1.53(1.08)

1.61(1.07)

0.06

Tc (mmol/L)

6.0 (0.21)

5.8 (0.16)

5.9 (0.14

5.9 (0.35)

5.5 (0.18)

5.7 (0.16)

0.25

LDLc(mmol/L)

3.91 (0.19)

3.63 (0.17)

3.8 (0.13)

3.68 (0.43)

3.71 (0.14)

3.7 (0.15)

0.65

HDL c (mmol/L)

1.22 (1.03)

1.13 (1.03)

1.17 (1.02)

1.26 (1.06)

1.13 (1.03)

1.19 (1.03)

0.51

Apo B (g/L)

1.28 (0.05)

1.20 (0.04)

1.23 (0.03)

1.33 (0.09)

1.24 (0.04)

1.26 (0.04)

0.53

ApoA1 (g/L)

1.2 (0.04)

1.13 (0.02)

1.16 (0.02)

1.2 (0.08)

1.18 (0.03)

1.21 (0.03)

0.24

Lp (a) g/L

0.32 (0.021–1.14)

0.14 (0.09–0.42)

0.24 (0.021–1.14)

0.38 (0.11–1.73)

0.200 (0.07–0.78)

0.33 (0.090–1.73)

0.12